A new study from the University of Cincinnati is raising concerns about the safety of the FDA approved COVID-19 treatment Remdesivir.
A new study from the University of Cincinnati is raising concerns about the safety of the FDA approved COVID-19 treatment Remdesivir.
The study found that patients were who giving a combination of the anti-inflammatory drug baricitinib and the antiviral drug..